Oligonucleotide · Heart/Blood-health
Inclisiran
Own facility · Oligonucleotide
Inclisiran is a long-acting siRNA therapeutic that lowers LDL cholesterol by targeting PCSK9, dosed twice yearly after initial doses. BOOKPHARM supports inclisiran as an active ingredient and through oligonucleotide CDMO.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFOligonucleotide | CDMO | CDMO |
| APIHeart/Blood-health | API supply | GMP+DMF |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.